IHS Chemical Week

Regions :: North America :: U.S.

Bayer to Acquire Teva’s U.S. Animal Health Business for $145 Million

1:43 PM MDT | September 14, 2012 | Deepti Ramesh

Bayer and Teva Pharmaceutical Industries (Petach Tikva, Israel) say that Bayer HealthCare has signed an agreement to acquire Teva's U.S. animal health business for up to $145 million. The purchase price includes an upfront payment of $60 million and a total of $85 million in milestone payments, which are linked to the successful and timely achievement of manufacturing and sales targets. The acquisition will reinforce the food animal franchise of Bayer HealthCare by providing a range of anti-infective solutions for livestock and by introducing reproductive...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa